| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | Patrick Media 22 Black | Genotype:cPLA2α KI | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 25 | Genotype:cPLA2α KI | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 33 | Genotype:cPLA2α KI | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 37 | Genotype:cPLA2α KI | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 40 | Genotype:cPLA2α KI | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 41 | Genotype:cPLA2α KI | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 42 | Genotype:cPLA2α KI | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media KI | Genotype:cPLA2α KI | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 28 | Genotype:cPLA2α KO | Treatment:CMV control Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 29 | Genotype:cPLA2α KO | Treatment:CMV control Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 32 | Genotype:cPLA2α KO | Treatment:CMV control Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 1 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 10 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 11 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 12 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 2 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 3 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 4 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 5 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 6 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 7 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 8 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 9 | Genotype:cPLA2α KO | Treatment:cPLA2α KI Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 23 Black | Genotype:cPLA2α KO | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 24 | Genotype:cPLA2α KO | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 30 | Genotype:cPLA2α KO | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 13 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 14 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 15 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 16 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 17 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 18 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 19 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 20 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 21 | Genotype:cPLA2α KO | Treatment:Wild Type Virus | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 26 | Genotype:Wild Type | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 27 | Genotype:Wild Type | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 31 | Genotype:Wild Type | Treatment:Pyrrophenone (50nM) | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 34 | Genotype:Wild Type | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 38 | Genotype:Wild Type | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 39 | Genotype:Wild Type | Treatment:Untreated | pmol of lipid |
| Reversed phase NEGATIVE ION MODE | Patrick Media 43 | Genotype:Wild Type | Treatment:Untreated | pmol of lipid |
Return to study ST001254 main page
Download data matrix(Eicosanoid profiles of dermal fibroblasts (part-II) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|